Correlation Between Gilead Sciences and Aptevo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Aptevo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Aptevo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Aptevo Therapeutics, you can compare the effects of market volatilities on Gilead Sciences and Aptevo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Aptevo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Aptevo Therapeutics.

Diversification Opportunities for Gilead Sciences and Aptevo Therapeutics

GileadAptevoDiversified AwayGileadAptevoDiversified Away100%
-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Gilead and Aptevo is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Aptevo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptevo Therapeutics and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Aptevo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptevo Therapeutics has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Aptevo Therapeutics go up and down completely randomly.

Pair Corralation between Gilead Sciences and Aptevo Therapeutics

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.17 times more return on investment than Aptevo Therapeutics. However, Gilead Sciences is 5.73 times less risky than Aptevo Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Aptevo Therapeutics is currently generating about -0.18 per unit of risk. If you would invest  8,944  in Gilead Sciences on November 22, 2024 and sell it today you would earn a total of  1,821  from holding Gilead Sciences or generate 20.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  Aptevo Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -60-40-20020
JavaScript chart by amCharts 3.21.15GILD APVO
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb9095100105110
Aptevo Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aptevo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb468101214

Gilead Sciences and Aptevo Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-4.88-3.66-2.43-1.210.01.272.593.915.236.54 0.050.100.15
JavaScript chart by amCharts 3.21.15GILD APVO
       Returns  

Pair Trading with Gilead Sciences and Aptevo Therapeutics

The main advantage of trading using opposite Gilead Sciences and Aptevo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Aptevo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will offset losses from the drop in Aptevo Therapeutics' long position.
The idea behind Gilead Sciences and Aptevo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance